Member Info for EmeraldCarrots

Hello!

31st July, FDA approval being applied for. What is there not to like? Sp is a total joke.

All IMHO.

Hello.

Raised money in May.

Ask 3.95p.

All IMHO.

Keep slowly going up over the coming weeks. This machine is unique. There will be a WORLD WIDE sales oppertunity when they get FDA approval. Market cap of £20m is plain stupid. No one can deny that.

All IMHO.

They are applying for FDA approval for their machine. The sp is a total and utter joke IMHO. Any Co. could snap Gendrive up at any moment. It is a ridiculous situation. Ridiculous IMHO. How on Earth is this even possible?

MAD IMHO.

How much is the only question if you ask me. The market cap is beyond ludicrous. A USA company probably, and any day I expect. The market cap is quite litrally unbelieveable. Is someone having a laugh, or what?

All IMHO.

How much if you ask me. The market cap is beyond ludicrous. A USA company probably, and any day I expect.

All IMHO.

Https://www.stocktitan.net/news/ANPCY/angle-plc-announces-standard-form-for-notification-of-major-4j53naqrsfct.html

X Golman Sachs I think.

Are taking on a lot of new staff from what I can gather in anticipation of, I think, this deal turning to gold in due course. I believe they are confident the assay will give the correct HER2 status in the pilot scheme. If it does and the drug goes to the phase III stage then things will take off, along with the sp. Even if this drug trial fails, they will still have the Assay as they own it to offer to others in other trials. Thus, the assay will be worth a mint if it works! All IMHO.

https://www.lse.co.uk/rns/AGL/contract-announcement-with-eisai-inc-49aplx5us0gzg6h.html

Excellent.

15p/15.25p.

Did not expect that. Good though.

LOL!

Ah, ask went to 15p as I posted that. Too late. LOL!

Hello.

£13.50 plus today I think.

............Hello.

Jackbal.

EC - 40% of full year forecast according to your Bloomberg source is 2.58 million.

Do you agree?

If you do agree then how can 40% of Full year revenue already be contracted when revenue for H1 is only “expected” to be between 1 - 1.3 million?

Am I misunderstanding the statement of are your maths wrong?

Or are you saying these contracts are heavily weighed to H2? If so why would that be?

-----------------------------------------------

Clearly they think contracts are heavily weighed to H2. That, presumably will be the effect of securing the contracts with Eisai Inc. and Astrazeneca. That reminds me. Mr Newland mentioned Roche several times and I don't remember him mentioning them before. Nothng specific of course. Hmmmmmm....... Makes one wonder.

All IMHO.